The retirement wave, in numbers
The demographic story is not subtle. According to AAMC physician workforce data, roughly 45% of active U.S. physicians are 55 or older, and more than one in five is already past 65. AAMC projects a shortfall of up to 86,000 physicians by 2036, with retirement the single largest driver. At the same time, AMA benchmark data shows the share of physicians working in practices they own has fallen below half, from 76% in the 1980s to roughly 42% today.
Put those two trends together and you get the defining condition of the next decade: a large, simultaneous supply of practices for sale, meeting a smaller pool of physicians who have been trained to be employees rather than owners. Supply up, prepared buyers down. That is a buyer’s market for anyone who waits — and a seller’s market for anyone who builds their successor pipeline early.
Who the next-generation buyer actually is
Selling to a new or upcoming doctor fails most often because the seller markets the practice they built rather than the practice the buyer wants to run. The buyer profile has changed:
- They carry debt, not cash. Median medical education debt sits near $200,000. They are not writing you a check; they are underwriting a loan payment against your cash flow.
- They price lifestyle. Call burden, panel size, admin load and schedule control are real line items to them. A practice that requires 60 clinical hours a week is worth less to this buyer than one that runs on 40.
- They expect systems, not heroics. Modern EHR hygiene, documented workflows, working revenue-cycle management and a marketing engine that produces new patients without the founder’s personal network.
- They research you online first. Reviews, branded search results and a visible growth story do the same job for a physician buyer that they do for a patient — they establish that the asset is real.
Why internal succession usually wins
The best-executed physician exits are rarely auctions. They are internal successions: recruit the successor as an associate, prove the economics to them with open books, then sell equity in stages. Four reasons this structure outperforms:
- · Patient retention. Attrition in a warm, physician-introduced handoff is a fraction of a cold ownership change. Retained patients are retained revenue, and retained revenue is what the buyer is financing.
- · Financing gets easier. Lenders underwrite a buyer with two years of production inside the same practice very differently than an outside physician with a pro forma.
- · Price discovery without a broker. No teaser, no CIM, no 3–8% success fee, and no confidentiality leak to staff and referrers.
- · You control the terms. Post-close clinical role, hours, wind-down schedule and legacy commitments are negotiated with someone who already trusts you.
If no internal candidate exists yet, that is the first project — not the sale. Twelve months of deliberate associate recruiting is cheaper than one turn of multiple lost in a distressed sale.
Pricing a practice for an individual buyer
Individual-physician deals are priced on normalized earnings, not revenue and not sentiment. Typical market ranges for physician-to-physician transactions:
| Practice type | Typical multiple | What moves it |
|---|---|---|
| Primary care / internal medicine | 2.5–4x adj. EBITDA (0.5–0.8x collections) | Panel size, payor mix, ancillary revenue |
| Specialty (derm, ortho, GI, ophtho) | 4–7x adj. EBITDA | Procedure mix, referral diversity, ASC access |
| Aesthetics / MedSpa / concierge | 4–8x adj. EBITDA | Recurring memberships, brand strength, cash-pay share |
| Solo, founder-dependent | Assets + 1–2x adj. EBITDA | Transferability of patient relationships |
Hard assets, inventory and accounts receivable are usually valued separately. The decisive variable in every row is the same one: how much of the cash flow survives your departure. Our companion pillar on enhancing practice valuation strategies breaks down each multiple-expansion lever.
How a young doctor pays for it
The affordability objection is usually solvable with structure rather than price concession. The standard stack:
- SBA 7(a) or conventional practice loan — 60–80%. SBA 7(a) supports acquisitions up to $5 million with roughly 10% equity injection and 10-year amortization; healthcare lenders treat physician borrowers as low-default risk.
- Seller note — 10–25%. Financing part of the price yourself signals confidence, often raises the total price, and converts a lump sum into interest-bearing income spread across tax years.
- Buyer equity injection — 10%. Frequently funded from signing bonus, savings or family capital.
- Sweat-equity earn-in. A defined share of collections above an agreed baseline is credited toward the purchase price during the associate period.
Run the buyer’s math before you set a price. If the post-close debt service plus a market physician salary does not leave a comfortable margin against your actual EBITDA, the deal will not be financed — no matter how good the practice is.
Deal structures that actually close
1. Staged equity buy-in (most common)
Successor purchases 30–49% at year one, the balance in tranches over three to five years, valued by a pre-agreed formula so neither party re-litigates price later. Lowest financing hurdle, best patient continuity.
2. Associate-to-owner with option
Employment for 18–24 months with a written purchase option at a formula price. Gives both sides a clean exit if the fit is wrong, and gives the lender a production history.
3. Full sale with transition employment
One closing, with the seller staying on part-time for 12–24 months. Fastest liquidity, highest attrition risk, and normally the lowest headline price.
4. Group merge, then internal succession
Merge into a like-minded independent group, then retire out of the combined entity. Preserves independence, adds scale, and hands the succession problem to a bench that already exists.
The 36-month transition timeline
- Months 0–6 — Diagnose and clean. Normalize EBITDA, move to monthly accrual books, document add-backs, confirm the lease and payor contracts are assignable, get a defensible valuation.
- Months 6–12 — Recruit the successor. Residency and fellowship directors, specialty societies, locum coverage physicians, and your own site. Hire for ownership temperament, not just clinical fit.
- Months 12–24 — De-risk the founder dependency. Shift new-patient routing, transfer referral relationships in person, document SOPs, stand up a marketing engine that produces patients without your name attached.
- Months 24–30 — Paper the deal. Purchase agreement, formula valuation, seller note, lender term sheet, restrictive covenants, real-estate treatment, tax structure with your CPA.
- Months 30–36 — Hand off publicly. Announce to patients, staff and referrers with the successor beside you. Step down clinically on a published schedule so the transition is visible and orderly.
What raises your price with this buyer
- Physician-independent revenue. Every dollar that arrives because of the practice rather than because of you is a dollar the buyer will pay full multiple for.
- Branded demand. Ranked local search, review velocity and a working Google Business Profile are the clearest proof that new patients will keep arriving after you leave.
- Recurring revenue. Memberships, retention programs and contracted services are worth multiples of the same dollar in transactional volume.
- A leadership bench. A practice manager who can run operations means the buyer is purchasing a business, not a job.
- Clean, lender-ready books. Three years of monthly accrual financials with a documented add-back schedule shortens diligence and removes the buyer’s best price-reduction argument.
Seven mistakes that kill succession deals
- Starting at 62. Preparation compresses into a fire sale. Start the plan a decade out; execute it over three years.
- Pricing on what you need to retire. Buyers and lenders price on earnings. Your retirement number is not an input.
- Tax-minimized books. Books designed to reduce taxable income also reduce financeable earnings. Convert early.
- No successor pipeline. Without a candidate you have one buyer type left — whoever calls — and no leverage.
- Unassignable lease or contracts. A landlord consent clause or a non-assignable payor contract discovered in diligence can reset the whole deal.
- Never leaving. A seller who stays too long or too visibly prevents the successor from inheriting authority — and patients notice.
- No marketing engine. If new-patient flow is the founder’s reputation, the buyer is financing a decaying asset — and will price it that way.
Frequently asked questions
What is the best way to sell my practice to a younger doctor?
A staged internal succession almost always beats a straight third-party sale. Recruit the successor as an associate 18–36 months before your exit, prove the economics to them with open books, then sell equity in tranches — often 30–49% first, with the balance bought over three to five years. This structure solves the buyer's financing problem, protects patient and referral continuity, and typically preserves more of your total after-tax proceeds than a discounted quick sale.
How many physicians are approaching retirement?
The Association of American Medical Colleges reports that roughly 45% of active U.S. physicians are 55 or older, and more than 20% are 65 or older. AAMC projects a shortfall of up to 86,000 physicians by 2036, driven heavily by retirements. That is the retirement wave: a large volume of practices coming to market at the same time, which favors owners who prepare early.
Can a new doctor actually afford to buy my practice?
Yes, more often than owners assume. The median medical school debt is about $200,000, which frightens sellers — but SBA 7(a) loans routinely finance practice acquisitions up to $5 million with roughly 10% equity injection and 10-year amortization, and lenders view physician borrowers as low-default. Combining bank debt with seller financing of 10–25% and an earn-in period makes the payment affordable out of practice cash flow.
How is a practice priced when selling to an individual physician?
Individual-buyer deals are usually priced on seller's discretionary earnings or normalized EBITDA rather than a strategic multiple. Primary care practices commonly trade around 0.5–0.8x annual collections or 2.5–4x adjusted EBITDA; procedural and specialty practices trade higher, often 4–7x. Hard assets, supplies and AR are valued separately. A private-equity platform may quote a higher headline multiple, but the net after earnout, rollover and post-close employment terms is frequently comparable.
How long should a practice transition take?
Plan 18–36 months. Twelve months is enough to transfer charts, not relationships. Patient attrition in physician-to-physician transitions drops sharply when the outgoing owner co-manages care and personally introduces the successor over at least four consecutive quarters.
What kills succession deals most often?
Four things: books that were built for taxes instead of underwriting, revenue that is entirely dependent on the founder, a lease or payor contract that cannot be assigned, and a price set by emotion rather than earnings. Each is fixable — but only with lead time.
Should I sell to private equity instead?
It depends on what you are optimizing for. PE pays the highest headline multiple and requires standardization, an earnout and usually equity rollover with a 2–5 year post-close clinical commitment. Selling to a new or upcoming physician typically yields a lower headline number but faster autonomy, cleaner patient continuity, seller-note interest income, and a legacy outcome many owners value more than the last turn of multiple.
Where do I find an upcoming doctor to buy my practice?
Residency and fellowship program directors in your specialty, state and specialty society job boards, locum and part-time coverage physicians who already know your systems, and — increasingly — your own website. Younger physicians research practices the way patients do; a practice with strong branded search presence, real reviews and a visible succession story attracts inbound successor interest without a broker.